CSIMarket
 


HOSPIRA, INC.  (HSP)
Other Ticker:  
 
 

HSP's EPS Net Growth by Quarter and Year

Hospira,'s EPS Net results by quarter and year




HSP EPS Net (in $) FY 2014 FY 2013 FY 2012 FY 2011
IV Quarter December - 0.20 0.03 -1.30
III Quarter September 0.92 0.01 0.01 -0.54
II Quarter June 0.42 0.20 -0.02 0.85
I Quarter March 0.40 -0.46 0.24 0.88
FY   1.74 -0.05 0.26 -0.11



HSP EPS Net third quarter 2014 Y/Y Growth Comment
HOSPIRA, INC. achieved in the third quarter, above Company average EPS Net surge of 9100% year on year, to $ 0.92 .

Among companies who have reported third quarter results in the Major Pharmaceutical Preparations industry only one Company has achieved higher year on year EPS Net results in the third quarter. While Hospira, Inc.' s EPS Net doubling of 9100% ranks overall at the positon no. 98 in the third quarter.




HSP EPS Net ( Y/Y Growth %) 2014
2013 2012 2011
IV Quarter December - 566.67 % - -
III Quarter September 9100 % 0 % - -
II Quarter June 110 % - - 73.47 %
I Quarter March - - -72.73 % 4.76 %
FY   - - - -

Financial Statements
Hospira,'s third quarter 2014 EPS Net $ 0.92 HSP's Income Statement
Hospira,'s third quarter 2013 EPS Net $ 0.01 Quarterly HSP's Income Statement
New: More HSP's historic EPS Net Growth >>


HSP EPS Net (Quarter on Quarter Growth %)

2014
2013 2012 2011
IV Quarter December - 1900 % 200 % -
III Quarter September 119.05 % -95 % - -
II Quarter June 5 % - - -3.41 %
I Quarter March 100 % - - 144.44 %
FY (Year on Year)   - - - -




EPS Net third quarter 2014 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #2
Healthcare Sector #5
Overall #98

EPS Net Y/Y Growth Statistics
High Average Low
88.35 % 6.26 % -45.95 %
(Sep. 30, 2014)   (March 31, 2007)
EPS Net third quarter 2014 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #2
Healthcare Sector #5
Overall #98
EPS Net Y/Y Growth Statistics
High Average Low
88.35 % 6.26 % -45.95 %
(Sep. 30, 2014)   (March 31, 2007)

EPS Net by Quarter for the Fiscal Years 2011, 2012, 2013, 2014

Hospira,'s Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
1900 % 87.08 % -95 %
(Dec 31 2013)  


HSP's III. Quarter Q/Q EPS Net Comment
HOSPIRA, INC. achieved in the III. Quarter 2014 above company average sequential EPS Net doubling of 119.05%, to $ 0.92 , from $0.42 in the second quarter.
HSP is impressively improving, with claiming better then normal increase, but also accelerating rate.

Within Major Pharmaceutical Preparations industry 5 other companies have achieved higher EPS Net quarter on quarter growth. While Hospira,'s EPS Net growth quarter on quarter, overall rank is 265.


EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #6
Healthcare Sector #17
Overall #265
EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #6
Healthcare Sector #17
Overall #265
EPS Net Q/Q Growth Statistics
High Average Low
1900 % 87.08 % -95 %
(Dec 31 2013)  


HSP's III. Quarter Q/Q EPS Net Comment
HOSPIRA, INC. achieved in the III. Quarter 2014 above company average sequential EPS Net doubling of 119.05%, to $ 0.92 , from $0.42 in the second quarter.
HSP is undergoing a remarkable growth, not only reporting above regular growth, and additionally accelerating pace, William  T. Walker, Major Pharmaceutical Preparations industry consultant situated in Glasgow said.

Within Major Pharmaceutical Preparations industry 5 other companies have achieved higher EPS Net quarter on quarter growth. While Hospira,'s EPS Net growth quarter on quarter, overall rank is 265.


Hospira,'s 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Sep. 30, 2014)
12 Months Ending
(June 30. 2014)
12 Months Ending
(March 31, 2014)
12 Months Ending
(Dec 31 2013)
12 Months Ending
(Sep. 30, 2013)
Cumulative EPS Net 12 Months Ending $ 1.94 $ 1.03 $ 0.81 $ -0.05 $ -0.22
Y / Y EPS Net Growth (TTM) - - - - -
Year on Year EPS Net Growth Overall Ranking # # # # #
Seqeuential EPS Net Change (TTM) 88.35 % 27.16 % - - -
Seq. EPS Net Growth (TTM) Overall Ranking # 98 # 128 # 0 # 0 # 0




Cumulative EPS Net growth Comment
Hospira, saw improvement in EPS Net growth trend, posting cumulative 12 months EPS Net growth of 9100% year on year, to $ 2 if the fiscal year would have ended in Sep. 30, 2014.
Hospira,'s trailing twelve months EPS Net growth was higher than company's average 14.54% and higher than % growth in June 30. 2014. And, Hospira, realized the fastest EPS Net growth, in Major Pharmaceutical Preparations industry.
But from twelve months ended June 30. 2014 growth rate was beneth at 88.35 % from $1.03 recorded in twelve months ending a quarter June 30. 2014.
Still this was confirmation of positive momentum, while the usual Q/Q TTM gain is at 6.26%.
The progress was much stronger sequentially clinched at 88.35 % rise from $1.03 in the period from June 30. 2014 to Sep. 30, 2013. In the Sep. 30, 2014 period, Hospira, had cumulative twelve months EPS Net of $ 2 compare to EPS net loss of $ -0 a year ago.
Not only that Major Pharmaceutical Preparations company has regained the prosperity, Hospira, by this time is improving fast and recording better then usual EPS Net rise, from the period from June 30. 2014 to Sep. 30, 2013 of 88.35 % from $1.03 .
There is revival on the way, but very slow one, reporting below usual 88.35 % EPS Net increase, from $1.03 from the period from June 30. 2014 to Sep. 30, 2013 William  T. Walker mentioned.

HOSPIRA, INC. achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
88.35 %
6.26 %
-45.95 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

EPS Net TTM Y/Y Growth Statistics
High Average Low
167.65 %
14.54 %
-51.47 %
(Sep. 30, 2008)  


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 5
S&P 500 # 98
Cumulative EPS Net growth Comment
Hospira, saw improvement in EPS Net growth trend, posting cumulative 12 months EPS Net growth of 9100% year on year, to $ 2 if the fiscal year would have ended in Sep. 30, 2014.
Hospira,'s trailing twelve months EPS Net growth was higher than company's average 14.54% and higher than % growth in June 30. 2014. And, Hospira, realized the fastest EPS Net growth, in Major Pharmaceutical Preparations industry.
But from the previous reporting period rise was less at 88.35 % from $1.03 achieved in the period from June 30. 2014 to Sep. 30, 2013 William  T. Walker continued.
In spite of, it was validation of strength, as the average Q/Q TTM advancement lays at 6.26%.
The progress was even more impressive sequentially showed at 88.35 % increase from $1.03 in twelve months ending a quarter June 30. 2014. In the Sep. 30, 2014 period, Hospira, had cumulative twelve months EPS Net of $ 2 compare to EPS net loss of $ -0 a year ago.
Besides Hospira, has restored the bottom-line, the company is already heading full steam and recording higher than average EPS Net surge, from the twelve months ending in the quarter June 30. 2014 of 88.35 % from $1.03 .
There is revival on the way, although with caution, reporting beneth usual 88.35 % EPS Net rise, from $1.03 from the period from June 30. 2014 to Sep. 30, 2013.

HOSPIRA, INC. achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
88.35 %
6.26 %
-45.95 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

EPS Net TTM Y/Y Growth Statistics
High Average Low
167.65 %
14.54 %
-51.47 %
(Sep. 30, 2008)  


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 5
S&P 500 # 98




Other EPS Net Growth
Major Pharmaceutical Preparations Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
HSP's EPS Net Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for HSP's Competitors
EPS Net Growth for Hospira,'s Suppliers
EPS Net Growth for HSP's Customers

You may also want to know
HSP's Annual Growth Rates HSP's Profitability Ratios HSP's Asset Turnover Ratio HSP's Dividend Growth
HSP's Roe HSP's Valuation Ratios HSP's Financial Strength Ratios HSP's Dividend Payout Ratio
HSP's Roa HSP's Inventory Turnover Ratio HSP's Growth Rates HSP's Dividend Comparisons



Companies with similar EPS Net doubling for the quarter ending Sep. 30, 2014 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Sep. 30, 2014
HOSPIRA, INC.9,100.00%$ 9,100.000 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PROV's Profile

Stock Price

PROV's Financials

Business Description

Fundamentals

Charts & Quotes

PROV's News

Suppliers

PROV's Competitors

Customers & Markets

Economic Indicators

PROV's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071